Abstract
BackgroundPegloticase is often the last treatment option for patients (pts) with uncontrolled/refractory gout but anti-drug antibodies (ADAs) cause loss of serum urate [SU] lowering response and infusion reactions (IRs).[1] MIRROR...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
